Abstract
While a genetic basis for thoracic aortic aneurysm and dissection is well established, little is known about endovascular stent graft therapy (TEVAR) outcomes in patients with family history of aortic disease following Type B acute aortic dissection (TBAD). Patients enrolled in the International
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have